ADVANCED NMR SYSTEMS INC
NT 10-Q, 1997-05-15
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: WINTHROP GROWTH INVESTORS I LP, 10QSB, 1997-05-15
Next: MAXICARE HEALTH PLANS INC, 10-Q, 1997-05-15





                       U.S. SECURITIES AND EXCHANGE COMMISSION

                                Washington, D.C. 20549

                                     FORM 12b-25
                                                                SEC FILE NUMBER
                            NOTIFICATION OF LATE FILING                 0-11910

                                                                 CUSIP NUMBER



     (Check One):  
                    [ ]Form 10-K and Form 10-KSB  [ ]Form 20-F 
                    [ ] Form 11-K [X]Form 10-Q and Form 10-QSB [ ]Form N-SAR
                    For Period Ended:   March 31, 1997
                    [ ] Transition Report on Form 10-K
                    [ ] Transition Report on Form 20-F
                    [ ] Transition Report on Form 11-K
                    [ ] Transition Report on Form 10-Q
                    [ ] Transition Report on Form N-SAR
                    For the Transition Period Ended:


     --------------------------------------------------------------------------
     Read Attached Instruction Sheet Before Preparing Form. Please Print or
     Type.

     Nothing in this form shall be construed to imply that the Commission has
     verified any information contained herein.
     --------------------------------------------------------------------------

     If the notification relates to a portion of the filing checked above,
     identify the Item(s) to which the notification relates:

          Not Applicable.
     ---------------------------------------------------------------------------

                           PART I - REGISTRANT INFORMATION

     ---------------------------------------------------------------------------

     Full Name of Registrant:      Advanced NMR Systems, Inc.

     Former Name if Applicable:          --------------

                        46 Jonspin Road, Wilmington, MA 01887
     ---------------------------------------------------------------------------
                        Address of Principal Executive Office
                    (Street and Number), City, State and Zip Code



                          PART II - RULES 12b-25(b) AND (c)

     If the subject report could not be filed without unreasonable effort or
     expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
     following should be completed.  (Check box if appropriate)

     [x]    (a)  The reasons described in reasonable detail in Part III of this
                 form could not be eliminated without unreasonable effort or
                 expense;

     [x]    (b)  The subject annual report, semi-annual report, transition
                 report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
                 thereof will be filed on or before the fifteenth calendar day
                 following the prescribed due date; or the subject quarterly
                 report or transition report on Form 10-Q, or portion thereof
                 will be filed on or before the fifth calendar day following the
                 prescribed due date; and

     [ ]    (c)  The accountant's statement or other exhibit required by Rule
                 12b-25(c) has been attached if applicable.

<PAGE> 
     --------------------------------------------------------------------------
                                 PART III - NARRATIVE
     --------------------------------------------------------------------------

     State below in reasonable detail the reasons why Form 10-K and 10-KSB, 11-
     K, 10-Q and 10-QSB, N-SAR, or the transition report or portion thereof
     could not be filed within the prescribed time period.  (Attach Extra Sheets
     if Needed)

          Registrant experienced delays in compiling the necessary information
     to complete the report. 

     --------------------------------------------------------------------------
                             PART IV - OTHER INFORMATION
     --------------------------------------------------------------------------

     (1)  Name and telephone number of person to contact in regard to this
          notification

                 Stephen James                508            657-8876
          ----------------------------       ----------     -----------------
                 (Name)                      (Area Code)    (Telephone Number)

     (2)  Have all other periodic reports required under section 13
          or 15(d) of the Securities Exchange Act of 1934 or section
          30 of the Investment Company Act of 1940 during the preceding
          12 months (or for such shorter) period that the registrant 
          was required to file such report(s) been filed?  If answer 
          is no, identify report(s).
                                                                   [X]Yes  [ ]No
          ______________________________________________________________________

     (3)  Is it anticipated that any significant change in results of
          operations from the corresponding period for the last fiscal
          year will be reflected by the earnings statements to be 
          included in the subject report or portion thereof?
                                                                  [ ]Yes  [X]No

          If so, attach an explanation of the anticipated change, both
          narratively and quantitatively, and, if appropriate, state the reasons
          why a reasonable estimate of the results cannot be made.


                              Advanced NMR Systems, Inc.
                   ------------------------------------------------------
                         (Name of Registrant as specified in charter)

     has caused this notification to be signed on its behalf by the undersigned
     thereunto duly authorized.

     Date:  May 14, 1997                By:  /s/ Steven James
          ------------------              -------------------------------------
                                        Name:     Steven James
                                        Title:    Chief Financial Officer

     INSTRUCTION:  The form may be signed by an executive officer of the
     registrant or by any other duly authorized representative.  The name and
     title of the person signing the form shall be typed or printed beneath the
     signature.  If the statement is signed on behalf of the registrant by an
     authorized representative (other than an executive officer), evidence of
     the representative's authority to sign on behalf of the registrant shall be
     filed with the form.

     -------------------------------------------------------------------------
                                      ATTENTION
     -------------------------------------------------------------------------
     Intentional misstatements or omissions of fact constitute Federal Criminal
     Violations (See 18 U.S.C.) 1001).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission